Taysha Doses First Patient in Pivotal Trial for Rett Syndrome Gene...
Taysha Gene Therapies has announced its dosing of the first patient in the pivotal phase 3 portion (Part B) of the REVEAL clinical...
PreciseOnco research consortium awarded EUR 14.9 million IHI grant to drive...
February 3, 2026 Co-funded by the EU’s Innovative Health Initiative (IHI), the...
Multiple Myeloma: Improved Prognosis With the Latest Treatments
Note: This story was originally published in 2022 and has been updated.Saad Usmani, MD, a hematologic oncologist specializing in multiple myeloma, is Chief of...
Breakthrough in Cancer Treatment: Bulgarian Scientist Stops Tumor Growth and Metastasis...
Dr. Zdravka Medarova @bTV
A Bulgarian scientist has developed a drug that halts...
Gene Editing Breakthrough Offers New Hope for Head and Neck Cancer...
January 26, 2026Researchers at the ChristianaCare Gene Editing Institute have made an important advance in treating head and neck cancers. By using CRISPR gene...
Breakthrough sepsis drug shows promise in human trial
Researchers at Griffith University report encouraging progress toward treating sepsis after a Phase II clinical trial in China produced positive results. The study suggests...
Biogen’s litifilimab receives FDA Breakthrough Therapy Designation to further develop treatment...
The U.S. Food and Drug Administration (FDA) has granted Biogen’s investigational drug, litifilimab, Breakthrough Therapy Designation for the treatment of cutaneous lupus erythematosus (CLE,...
Breakthrough blood pressure treatment now available at MemorialCare Long Beach Medical...
By: David Shavelle, M.D., FACC, FSCAI, medical director, Adult Cardiology & Interventional Lab, MemorialCare Heart & Vascular Institute, Long Beach Medical Center
If you’ve been...
Pancreatic cancer breakthrough: tumors disappear in mice
Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of pancreatic cancer.
Notoriously aggressive and difficult to treat, pancreatic cancer...

































